Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Toprol-XL
Generic name / active ingredient
metoprolol succinate
Dosage-form class
Extended-release oral tablets: 25 mg, 50 mg, 100 mg and 200 mg (as listed in the current 2026 DailyMed label)
Route
Oral
Record reviewed
2026-08-30

Copy from the pack in hand

Source-linked reading points

  • Check TOPROL-XL, metoprolol succinate, extended-release tablet, stated strength per tablet and target market together. A shared “metoprolol” name or similar number does not prove products can be self-converted, substituted or alternated by tablet count.
  • “Extended release” describes a formulation's release design across the dosing interval; it is not a universal claim of being “stronger” or freely crushable. Splitting, swallowing method or changing to another form can only be confirmed from the current label for that exact product and a pharmacist.
  • The label identifies situations needing extra review with clonidine, digoxin or some calcium-channel blockers, and warns against self-directed abrupt discontinuation. With heart-rate changes, dizziness, chest discomfort or a changed medicine list, bring the actual pack to a clinician or pharmacist rather than self-adjusting or stopping from a webpage.

Reviewed presentation examples — compare every field

  • 25 mg per tablet; 100-tablet bottle (extended-release tablet)NDC 70842-110-02
  • 50 mg per tablet; 100-tablet bottle (extended-release tablet)NDC 70842-111-02
  • 100 mg per tablet; 100-tablet bottle (extended-release tablet)NDC 70842-112-02
  • 200 mg per tablet; 100-tablet bottle (extended-release tablet)NDC 70842-113-02

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-30
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image